Back to Search Start Over

Vision impairment and risk of frailty: the English Longitudinal Study of Ageing

Authors :
Sheena E Ramsay
Cesar de Oliveira
S. Goya Wannamethee
Kate Walters
Efstathios Papachristou
Ann E M Liljas
Livia A. Carvalho
Source :
The Lancet. 388:S70
Publication Year :
2016
Publisher :
Elsevier BV, 2016.

Abstract

Background Age-related vision impairment has been associated with comorbidities, current disability, and poor quality of life. However, it is unclear whether vision impairment is associated with increasing future frailty, further affecting ability to live independently. We investigated the association of poor vision with incident pre-frailty and frailty. Methods 2836 men and women aged 60 years or more with data on vision (self-reported vision problems) and frailty status (Fried phenotype) from the nationally representative English Longitudinal Study of Ageing were followed up for 4 years for pre-frailty and frailty between 2004 and 2008. Frailty was defined according to number of Fried phenotype components present (slow walking, weak grip, self-reported exhaustion, weight loss, low physical activity) as non-frail (0 components), pre-frail (1–2), and frail (≥3). Participants non-frail at baseline were followed up for incident pre-frailty and frailty. Participants pre-frail at baseline were followed up for incident frailty. Findings At baseline, 1396 participants (49%) were non-frail, 1178 (42%) pre-frail, and 262 (9%) frail. At follow-up, there were 367 new cases of pre-frailty and frailty among those non-frail at baseline, and 133 new cases of frailty among those pre-frail at baseline. Cross-sectional analysis showed an association between vision impairment and frailty (age-adjusted and sex-adjusted odds ratio 2·53, 95% CI 1·95–3·30; p Interpretation Older adults who experience poor vision and are not frail have double the risk of becoming pre-frail or frail over 4 years. Public health interventions aiming to identify and actively manage vision impairment might prevent frailty. Funding AEML is funded by the National Institute for Health Research School for Public Health Research (509546). LAC is funded by the British Heart Foundation (RG/10/001/28296) and the Medical Research Council (RG71546). SER is funded by a UK Medical Research Council fellowship (G1002391).

Details

ISSN :
01406736
Volume :
388
Database :
OpenAIRE
Journal :
The Lancet
Accession number :
edsair.doi...........f499d6356bab9896ea47df0ae7b313c7
Full Text :
https://doi.org/10.1016/s0140-6736(16)32306-6